Suraksha Diagnostic's Q2 FY 2025-26 Quarterly Results
- 06 Jan 2026
Result Summary
- Suraksha Diagnostic Ltd reported a 8.3% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 16.9%.
- Its expenses for the quarter were up by 8.8% QoQ and 23.7% YoY.
- The net profit decreased 3.8% QoQ and decreased 13.0% YoY.
- The earnings per share (EPS) of Suraksha Diagnostic Ltd stood at 1.73 during Q2 FY 2025-26.
Financial Statments for Q2 FY 2025-26
Total Income | 79.58 | 73.49 | 68.07 | 8.3% | 16.9% |
Total Expenses | 67.33 | 61.91 | 54.44 | 8.8% | 23.7% |
Profit Before Tax | 12.05 | 12.47 | 13.63 | -3.4% | -11.6% |
Tax | 3.22 | 3.29 | 3.48 | -2.1% | -7.5% |
Profit After Tax | 8.83 | 9.18 | 10.15 | -3.8% | -13.0% |
Earnings Per Share | 1.73 | 1.80 | 1.94 | -3.9% | -10.8% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Suraksha Diagnostic Ltd is a company operating within the healthcare sector, focusing primarily on diagnostic services. These services likely encompass a range of medical testing and analysis offered through a network of diagnostic centers. As a company in the healthcare industry, Suraksha Diagnostic Ltd may benefit from a consistent demand for medical services driven by both regular health check-ups and specialized diagnostic needs. Recent major developments for the company are not available from the provided data. Nonetheless, like many companies in the healthcare sector, it might be influenced by technological advancements, regulatory changes, and shifts in healthcare demand due to demographic trends or public health initiatives.
Revenue
In the second quarter of the fiscal year 2026 (Q2FY26), Suraksha Diagnostic Ltd reported a total income of ₹79.58 crores. This figure marks an increase from ₹73.49 crores in the previous quarter (Q1FY26), representing a quarter-over-quarter (QoQ) growth of 8.3%. Compared to the same quarter in the previous year (Q2FY25), where the total income was ₹68.07 crores, the company experienced a year-over-year (YoY) increase of 16.9%. These increases in total income may reflect positively on the company’s ability to generate revenue over both short and long-term periods.
Profitability
Suraksha Diagnostic Ltd's profitability metrics indicate a slight decline over the analyzed periods. The profit before tax (PBT) for Q2FY26 stood at ₹12.05 crores, a decrease from ₹12.47 crores in Q1FY26, which translates to a QoQ decline of 3.4%. When compared to Q2FY25, where the PBT was ₹13.63 crores, the YoY reduction is 11.6%. This declining trend is also evident in the profit after tax (PAT), which was ₹8.83 crores in Q2FY26, decreasing from ₹9.18 crores in Q1FY26 and ₹10.15 crores in Q2FY25. These figures represent declines of 3.8% QoQ and 13.0% YoY, respectively. The earnings per share (EPS) also saw similar patterns, with a QoQ decrease of 3.9% and a YoY decrease of 10.8%, settling at ₹1.73 in Q2FY26.
Operating Metrics
Total expenses for Suraksha Diagnostic Ltd have shown an upward trend, reaching ₹67.33 crores in Q2FY26 from ₹61.91 crores in the previous quarter, resulting in an 8.8% QoQ increase. When compared to Q2FY25, where total expenses were ₹54.44 crores, there is a notable YoY increase of 23.7%. The tax expenses also followed a downward trajectory, with a slight reduction from ₹3.29 crores in Q1FY26 to ₹3.22 crores in Q2FY26, showing a 2.1% decline. There was also a YoY decrease of 7.5% when compared to Q2FY25's tax expense of ₹3.48 crores. These figures highlight the company's cost dynamics and tax obligations over time.